# Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis

> **NCT03216915** · — · UNKNOWN · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Gilenya®; Novartis Pharmaceuticals Corporation

## Key facts

- **NCT ID:** NCT03216915
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216915, "Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03216915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*